Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03867838 · ClinicalTrials.gov registry record · NA
Effects of a Compliant Arm Support on Post-stroke Upper Extremity Range of Motion
A NA study of Arm Weakness as a Consequence of Stroke, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT03867838: Completed NA study of Arm Weakness as a Consequence of Stroke, sponsored by Stanford University.
NCT03867838 is a NA study of Arm Weakness as a Consequence of Stroke that has completed, run by Stanford University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03867838, a NA study of Arm Weakness as a Consequence of Stroke, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to show that a wearable compliant arm support consisting of inflatable bladders with adjustable straps to connect them to the waist and arm can meaningfully increase the reachable workspace of persons with post-stroke arm weakness.
Primary Outcome
Reachable workspace was measured using a PhaseSpace motion capture system, recorded as an area (in square meters).
Conditions Studied
Interventions
- DEVICE compliant support
Study Locations (1)
California
- Stanford University CHARM Lab - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-06-14 |
| Est. Completion | 2020-10-01 |
| Phase | NA |
What the finished NCT03867838 record still lists
NCT03867838 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Arm Weakness as a Consequence of Stroke appearing as the primary indexed condition, and to 1 intervention - of which compliant support is the first listed.
NCT03867838 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03867838 about?
NCT03867838 is a clinical study titled "Effects of a Compliant Arm Support on Post-stroke Upper Extremity Range of Motion". The aim of this study is to show that a wearable compliant arm support consisting of inflatable bladders with adjustable straps to connect them to the waist and arm can meaningfully increase the reachable workspace of persons with post-stroke arm weakness.
What is the current status of trial NCT03867838?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2019-06-14. Estimated completion is 2020-10-01.
What conditions does trial NCT03867838 study?
This clinical trial studies the following conditions: Arm Weakness as a Consequence of Stroke.
What interventions are being tested in trial NCT03867838?
The interventions under investigation include: compliant support (DEVICE).
Who is sponsoring clinical trial NCT03867838?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03867838 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arm Weakness as a Consequence of Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03867838's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI